Unknown

Dataset Information

0

An evolved Mxe GyrA intein for enhanced production of fusion proteins.


ABSTRACT: Expressing antibodies as fusions to the non-self-cleaving Mxe GyrA intein enables site-specific, carboxy-terminal chemical modification of the antibodies by expressed protein ligation (EPL). Bacterial antibody-intein fusion protein expression platforms typically yield insoluble inclusion bodies that require refolding to obtain active antibody-intein fusion proteins. Previously, we demonstrated that it was possible to employ yeast surface display to express properly folded single-chain antibody (scFv)-intein fusions, therefore permitting the direct small-scale chemical functionalization of scFvs. Here, directed evolution of the Mxe GyrA intein was performed to improve both the display and secretion levels of scFv-intein fusion proteins from yeast. The engineered intein was shown to increase the yeast display levels of eight different scFvs by up to 3-fold. Additionally, scFv- and green fluorescent protein (GFP)-intein fusion proteins can be secreted from yeast, and while fusion of the scFvs to the wild-type intein resulted in low expression levels, the engineered intein increased scFv-intein production levels by up to 30-fold. The secreted scFv- and GFP-intein fusion proteins retained their respective binding and fluorescent activities, and upon intein release, EPL resulted in carboxy-terminal azide functionalization of the target proteins. The azide-functionalized scFvs and GFP were subsequently employed in a copper-free, strain-promoted click reaction to site-specifically immobilize the proteins on surfaces, and it was demonstrated that the functionalized, immobilized scFvs retained their antigen binding specificity. Taken together, the evolved yeast intein platform provides a robust alternative to bacterial intein expression systems.

SUBMITTER: Marshall CJ 

PROVIDER: S-EPMC4340354 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

An evolved Mxe GyrA intein for enhanced production of fusion proteins.

Marshall Carrie J CJ   Grosskopf Vanessa A VA   Moehling Taylor J TJ   Tillotson Benjamin J BJ   Wiepz Gregory J GJ   Abbott Nicholas L NL   Raines Ronald T RT   Shusta Eric V EV  

ACS chemical biology 20141124 2


Expressing antibodies as fusions to the non-self-cleaving Mxe GyrA intein enables site-specific, carboxy-terminal chemical modification of the antibodies by expressed protein ligation (EPL). Bacterial antibody-intein fusion protein expression platforms typically yield insoluble inclusion bodies that require refolding to obtain active antibody-intein fusion proteins. Previously, we demonstrated that it was possible to employ yeast surface display to express properly folded single-chain antibody (  ...[more]

Similar Datasets

| S-EPMC6213604 | biostudies-literature
| S-EPMC10074672 | biostudies-literature
| S-EPMC179553 | biostudies-other
| S-EPMC3783209 | biostudies-literature
| S-EPMC8355345 | biostudies-literature
| S-EPMC3154154 | biostudies-literature
| S-EPMC8993541 | biostudies-literature
| S-EPMC3810395 | biostudies-literature
| S-EPMC7027934 | biostudies-literature
| S-EPMC8433393 | biostudies-literature